• NICE backs PredictImmune's IBD prognosis test pharmatimes
    April 02, 2019
    PredictImmune has announced that the National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on the use of its PredictSURE IBD technology, for the prognosis of inflammatory bowel disease.
PharmaSources Customer Service